Francois Rochon Edwards Lifesciences Corp Transaction History

Giverny Capital Inc.

$2.44 Billion
Q3 2024

A detailed history of Francois Rochon (Giverny Capital Inc.) transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Giverny Capital Inc. holds 446,288 shares of EW stock, worth $33.6 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares

446,288

Previous 446,016 0.06%

Holding current value

$33.6 Million

Previous $41.2 Million 28.52%

% of portfolio

1.21%

Previous 1.85%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$59.7 - $93.78 $16,238 - $25,508	272 Added 0.06%	446,288 $29.5 Million
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $25,121 - $28,104	298 Added 0.07%	446,016 $41.2 Million
Q1 2024 May 13, 2024	BUY	$72.54 - $95.56 $349,062 - $459,834	4,812 Added 1.09%	445,718 $42.6 Million
Q4 2023 Feb 09, 2024	BUY	$61.71 - $77.76 $18,759 - $23,639	304 Added 0.07%	440,906 $33.6 Million
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $48,911 - $65,926	706 Added 0.16%	440,602 $30.5 Million
Q2 2023 Aug 07, 2023	BUY	$81.41 - $94.33 $2.03 Million - $2.35 Million	24,921 Added 6.01%	439,896 $41.5 Million
Q1 2023 May 12, 2023	SELL	$74.26 - $84.51 $831,563 - $946,342	-11,198 Reduced 2.63%	414,975 $34.3 Million
Q4 2022 May 17, 2023	BUY	$68.3 - $87.44 $764,823 - $979,153	11,198 Added 2.7%	426,173 $31.8 Million
Q4 2022 Feb 10, 2023	SELL	$68.3 - $87.44 $274,770 - $351,771	-4,023 Reduced 0.94%	426,173 $31.8 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $1.1 Million - $1.43 Million	13,314 Added 3.19%	430,196 $35.5 Million
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $1.02 Million - $1.51 Million	11,791 Added 2.91%	416,882 $39.6 Million
Q1 2022 May 12, 2022	SELL	$101.96 - $128.34 $68,415 - $86,116	-671 Reduced 0.17%	405,091 $47.7 Million
Q4 2021 Feb 11, 2022	BUY	$106.37 - $130.68 $384,208 - $472,016	3,612 Added 0.9%	405,762 $52.6 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $347,732 - $414,772	-3,379 Reduced 0.83%	402,150 $45.5 Million
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $1.29 Million - $1.61 Million	15,389 Added 3.94%	405,529 $42 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $183,009 - $210,898	2,326 Added 0.6%	390,140 $32.6 Million
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $1.03 Million - $1.31 Million	14,392 Added 3.85%	387,814 $35.4 Million
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $53,416 - $69,514	795 Added 0.21%	373,422 $29.8 Million
Q2 2020 Aug 07, 2020	BUY	$57.54 - $76.95 $14.6 Million - $19.6 Million	254,201 Added 214.65%	372,627 $25.8 Million
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $528,764 - $817,209	-10,089 Reduced 7.85%	118,426 $22.3 Million
Q4 2019 Feb 07, 2020	BUY	$71.7 - $82.09 $91,919 - $105,239	1,282 Added 1.01%	128,515 $30 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $14,956 - $18,329	243 Added 0.19%	127,233 $28 Million
Q2 2019 Aug 13, 2019	BUY	$55.74 - $64.41 $170,954 - $197,545	3,067 Added 2.47%	126,990 $23.5 Million
Q1 2019 May 14, 2019	BUY	$47.89 - $64.05 $83,568 - $111,767	1,745 Added 1.43%	123,923 $23.7 Million
Q4 2018 Feb 13, 2019	SELL	$46.41 - $56.94 $2.72 Million - $3.33 Million	-58,512 Reduced 32.38%	122,178 $18.7 Million
Q3 2018 Nov 13, 2018	BUY	$45.7 - $58.03 $373,917 - $474,801	8,182 Added 4.74%	180,690 $31.5 Million
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $1.09 Million - $1.31 Million	-25,629 Reduced 12.93%	172,508 $25.1 Million
Q2 2018 Aug 13, 2018	BUY	$42.45 - $51.3 $1.14 Million - $1.38 Million	26,971 Added 15.76%	198,137 $28.8 Million
Q1 2018 May 11, 2018	BUY	$37.19 - $47.45 $356,838 - $455,282	9,595 Added 5.94%	171,166 $23.9 Million
Q4 2017 Feb 13, 2018	BUY	$33.79 - $39.39 $5.46 Million - $6.36 Million	161,571	161,571 $18.2 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track Francois Rochon's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Giverny Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Giverny Capital Inc. and Francois Rochon with notifications on news.

Account